BioSpace News Archive

Biomerica, Inc., a global provider of advanced medical products, reported its second quarter fiscal 2023 financial results for the period ended November 30, 2022.

Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Japanese pharmaceutical company Fuji Pharma Co., Ltd. have decided to expand their existing exclusive commercialization partnership covering Japan, by adding a new undisclosed biosimilar candidate.

Daxor Corporation today announces it will be presenting at the Society for Critical Care Medicine (SCCM) 2023 Critical Care Congress at the Moscone Center In San Francisco, CA from January 21 through the 24, 2023.

Immix Biopharma, Inc. today announced dosing of an additional patient in its ongoing Phase 1b/2a IMX-110 monotherapy clinical trial.

PDS Biotechnology Corporation today announced that its management will participate in a fireside chat at the B. Riley Securities 3rd Annual Oncology Conference being held virtually on January 18-19, 2023.

Neurocentria, Inc. has today announced that Dr. Thomas Südhof, Avram Goldstein Professor in Stanford University School of Medicine and an investigator of the Howard Hughes Medical Institute, has joined the company’s Scientific Advisory Board (SAB).

Hospital for Special Surgery has appointed experienced healthcare leader, Tara M. McCoy, to the new position of HSS Florida Chief Executive Officer.

Jasper Therapeutics, Inc. today announced that new positive data for briquilimab (formerly known as JSP191), will be presented at the 2023 Tandem Meetings: Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, taking place on February 15-19, 2023 in Orlando, Florida.

FSD Pharma Inc. is pleased to announce that its Board of Directors has authorized the repurchase under a normal course issuer bid (“NCIB”) of up to 1,925,210 of its Subordinate Class B Voting Shares (the “Subordinate Voting Shares”) from time to time over the next 12 months at prevailing market prices in order to allow the Company to use its excess cash reserves to strategically return value to shareholders.

Today, LCMC Health announced a $1.5 million gift to Xavier University of Louisiana to create and retain a diverse physician workforce in Louisiana.